BioVie Inc. (BIVI) vs Satellos Bioscience Inc. (MSLE)
A side-by-side comparison of BioVie Inc. and Satellos Bioscience Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BIVI
BioVie Inc.
$1.44HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
MSLE
Satellos Bioscience Inc.
$7.54HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BIVI vs MSLE
growth of $100 · dividends reinvested · last 1yBIVI +10.8% (+10.8%/yr)MSLE +13.7% (+13.7%/yr)MSLE compounded faster over this window
BIVI MSLE
BIVI vs MSLE: by the numbers
- •BIVI is the larger company ($11M vs $10M market cap).
Metrics side by side
Valuation
| Metric | BIVI | MSLE |
|---|---|---|
| P/B ratio | 1.06 | 0.16 |
Profitability
| Metric | BIVI | MSLE |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -214.92% | -57.34% |
| ROIC | -216.67% | -59.35% |
Growth (annualized)
| Metric | BIVI | MSLE |
|---|---|---|
| Total return CAGR (5Y) | -70.37% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.